Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Solid Tumors

Clinical Trial at: Minnesota Oncology - Minneapolis

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: Solid Tumors
USOR Number: 19079

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, MN 55404
P: (612) 884-6300

More Details View Practice Page

Solid Tumors

Clinical Trial at: Minnesota Oncology - Edina

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: Solid Tumors
USOR Number: 19079

  • Practice Details

6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900

More Details View Practice Page

Solid Tumors

Clinical Trial at: Minnesota Oncology - Coon Rapids

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: Solid Tumors
USOR Number: 19079

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: Breast Cancer
USOR Number: 19054

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Saint Paul

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: Breast Cancer
USOR Number: 19054

  • Practice Details

310 Smith Ave N
Suite 100
Saint Paul, MN 55102
P: (651) 251-5500

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: Breast Cancer
USOR Number: 19054

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, MN 55404
P: (612) 884-6300

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: Breast Cancer
USOR Number: 19054

  • Practice Details

1580 Beam Avenue
Maplewood, MN 55109
P: (651) 779-7978

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Edina

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: Breast Cancer
USOR Number: 19054

  • Practice Details

6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: Breast Cancer
USOR Number: 19054

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: Peritoneal Cancer
USOR Number: 19046

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page
1 … 3 4 5 6 7 … 12

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.